Cross-presentation of disialoganglioside GD3 to natural killer T cells

被引:226
作者
Wu, DY
Segal, NH
Sidobre, S
Kronenberg, M
Chapman, PB
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Swim Across Amer Lab, New York, NY 10021 USA
[3] La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA
关键词
NKT cell; alpha-galactosylceramide; CD1d; tetramer; melanoma;
D O I
10.1084/jem.20030446
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
GD3, a ganglioside expressed on human melanoma, can be recognized by the humoral immune system. In this paper, we demonstrate that immunizing mice with the human melanoma cell line SK-MEL-28 (GD3(+) GM2(-) CD1(-)) or with syngeneic APCs loaded with GD3 can induce a GD3-reactive natural killer T (NKT) cell response. GD3-reactive NKT cells were detected among splenocytes of immunized mice at frequencies of similar to1:2,000 both by ELISPOT and GD3-loaded mouse CD1d tetramer analysis. GD3-reactive NKT cells did not react with GM2, a closely related ganglioside, and were not detectable in unimmunized mice. GD3-reactive NKT cells initially produced IL-4 and IFN-gamma followed by IL-10. They were CD1d restricted in that reactivity was abrogated when APCs were blocked with anti-CD1d monoclonal antibody before being loaded with GD3 or when APCs from CD1d knockout mice were used. Because SK-MEL-28 does not express any isoform of human CD1, GD3 must be cross-presented by murine APCs in vivo. This is the first analysis of a natural ligand for mouse NKT cells and the first definitive paper of cross-presentation to NKT cells. This could be a mechanism for NKT cell recognition of tumor gangliosides in CD1(-) tumors.
引用
收藏
页码:173 / 181
页数:9
相关论文
共 37 条
[1]   Mouse CD1-specific NK1 T cells: Development, specificity, and function [J].
Bendelac, A ;
Rivera, MN ;
Park, SH ;
Roark, JH .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :535-562
[2]   CD1 RECOGNITION BY MOUSE NK1(+) T-LYMPHOCYTES [J].
BENDELAC, A ;
LANTZ, O ;
QUIMBY, ME ;
YEWDELL, JW ;
BENNINK, JR ;
BRUTKIEWICZ, RR .
SCIENCE, 1995, 268 (5212) :863-865
[3]   In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers [J].
Benlagha, K ;
Weiss, A ;
Beavis, A ;
Teyton, L ;
Bendelac, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (11) :1895-1903
[4]   CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution [J].
Brossay, L ;
Chioda, M ;
Burdin, N ;
Koezuka, Y ;
Casorati, G ;
Dellabona, P ;
Kronenberg, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08) :1521-1528
[5]  
Burdin N, 1998, J IMMUNOL, V161, P3271
[6]   INDUCTION OF IGG ANTIBODIES AGAINST GD3 GANGLIOSIDE IN RABBITS BY AN ANTIIDIOTYPIC MONOCLONAL-ANTIBODY [J].
CHAPMAN, PB ;
HOUGHTON, AN .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (01) :186-192
[7]  
CHAPMAN PB, 1990, CANCER RES, V50, P1503
[8]   A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas [J].
Crowe, NY ;
Smyth, MJ ;
Godfrey, DI .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (01) :119-127
[9]   CD1d-restricted help to B cells by human invariant natural killer T lymphocytes [J].
Galli, G ;
Nuti, S ;
Tavarini, S ;
Galli-Stampino, L ;
De Lalla, C ;
Casorati, G ;
Dellabona, P ;
Abrignani, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (08) :1051-1057
[10]   CD1d-restricted and TCR-mediated activation of V(alpha)14 NKT cells by glycosylceramides [J].
Kawano, T ;
Cui, JQ ;
Koezuka, Y ;
Toura, I ;
Kaneko, Y ;
Motoki, K ;
Ueno, H ;
Nakagawa, R ;
Sato, H ;
Kondo, E ;
Koseki, H ;
Taniguchi, M .
SCIENCE, 1997, 278 (5343) :1626-1629